[Intraarterial chemotherapy combined with radiation therapy for advanced cancer of the uterine cervix]. 1998

M Noguchi, and R Murata, and T Sagoh, and M Yamamoto, and H Ueda, and K Kinoshita, and M Ueta, and H Honda, and K Miyazaki, and T Sasaki, and T Tachibana
Dept. of Radiology, Fukui Red Cross Hospital.

The results of intraarterial chemotherapy (IACT) combined with definitive radiation therapy for 23 advanced and bulky carcinomas of uterine cervix are reported. IA-CT with cisplatin 50 mg and doxorubicin 30 mg was administered by one shot method in bilateral internal iliac arteries. The protocol consisted of one to three treatment session every 3 weeks. Nine of eleven patients with clinical stage III achieved a complete local response (82%), and the 3- and 5-year survival in these cases were 72% and 72%, respectively. These results were superior to the response (58%), 3- and 5-year survivals (68%, 58%) obtained in 19 patients treated mainly with radiation therapy alone. The side effect of grade 2 and 3 for the intestine, such as ileus and hemorrhagic colitis, was noted in 3 patients (15%). In addition, 3 of 8 patients with radical surgery and postoperative radiation therapy after IA-CT developed insufficient fracture of pelvic bone. These complications accompanied by IA-CT combined with radiation therapy and/or surgery increased slightly, compared with that by the previous therapy without IA-CT, but were not critical. The results suggest that IA-CT following radiation therapy is effective to improve the prognosis of patients with Stage III cervical cancer.

UI MeSH Term Description Entries
D007261 Infusions, Intra-Arterial Regional infusion of drugs via an arterial catheter. Often a pump is used to impel the drug through the catheter. Used in therapy of cancer, upper gastrointestinal hemorrhage, infection, and peripheral vascular disease. Infusions, Regional Arterial,Infusions, Intra Arterial,Infusions, Intraarterial,Arterial Infusion, Intra,Arterial Infusion, Regional,Arterial Infusions, Intra,Arterial Infusions, Regional,Infusion, Intra Arterial,Infusion, Intra-Arterial,Infusion, Intraarterial,Infusion, Regional Arterial,Intra Arterial Infusion,Intra Arterial Infusions,Intra-Arterial Infusion,Intra-Arterial Infusions,Intraarterial Infusion,Intraarterial Infusions,Regional Arterial Infusion,Regional Arterial Infusions
D011788 Quality of Life A generic concept reflecting concern with the modification and enhancement of life attributes, e.g., physical, political, moral, social environment as well as health and disease. HRQOL,Health-Related Quality Of Life,Life Quality,Health Related Quality Of Life
D011879 Radiotherapy Dosage The total amount of radiation absorbed by tissues as a result of radiotherapy. Dosage, Radiotherapy,Dosages, Radiotherapy,Radiotherapy Dosages
D011882 Radiotherapy, High-Energy Radiotherapy using high-energy (megavolt or higher) ionizing radiation. Types of radiation include gamma rays, produced by a radioisotope within a teletherapy unit; x-rays, electrons, protons, alpha particles (helium ions) and heavy charged ions, produced by particle acceleration; and neutrons and pi-mesons (pions), produced as secondary particles following bombardment of a target with a primary particle. Megavolt Radiotherapy,High-Energy Radiotherapy,Radiotherapy, Megavolt,High Energy Radiotherapy,Radiotherapy, High Energy
D002583 Uterine Cervical Neoplasms Tumors or cancer of the UTERINE CERVIX. Cancer of Cervix,Cancer of the Cervix,Cancer of the Uterine Cervix,Cervical Cancer,Cervical Neoplasms,Cervix Cancer,Cervix Neoplasms,Neoplasms, Cervical,Neoplasms, Cervix,Uterine Cervical Cancer,Cancer, Cervical,Cancer, Cervix,Cancer, Uterine Cervical,Cervical Cancer, Uterine,Cervical Cancers,Cervical Neoplasm,Cervical Neoplasm, Uterine,Cervix Neoplasm,Neoplasm, Cervix,Neoplasm, Uterine Cervical,Uterine Cervical Cancers,Uterine Cervical Neoplasm
D002945 Cisplatin An inorganic and water-soluble platinum complex. After undergoing hydrolysis, it reacts with DNA to produce both intra and interstrand crosslinks. These crosslinks appear to impair replication and transcription of DNA. The cytotoxicity of cisplatin correlates with cellular arrest in the G2 phase of the cell cycle. Platinum Diamminodichloride,cis-Diamminedichloroplatinum(II),cis-Dichlorodiammineplatinum(II),Biocisplatinum,Dichlorodiammineplatinum,NSC-119875,Platidiam,Platino,Platinol,cis-Diamminedichloroplatinum,cis-Platinum,Diamminodichloride, Platinum,cis Diamminedichloroplatinum,cis Platinum
D003131 Combined Modality Therapy The treatment of a disease or condition by several different means simultaneously or sequentially. Chemoimmunotherapy, RADIOIMMUNOTHERAPY, chemoradiotherapy, cryochemotherapy, and SALVAGE THERAPY are seen most frequently, but their combinations with each other and surgery are also used. Multimodal Treatment,Therapy, Combined Modality,Combined Modality Therapies,Modality Therapies, Combined,Modality Therapy, Combined,Multimodal Treatments,Therapies, Combined Modality,Treatment, Multimodal,Treatments, Multimodal
D004317 Doxorubicin Antineoplastic antibiotic obtained from Streptomyces peucetius. It is a hydroxy derivative of DAUNORUBICIN. Adriamycin,Adriablastin,Adriablastine,Adriblastin,Adriblastina,Adriblastine,Adrimedac,DOXO-cell,Doxolem,Doxorubicin Hexal,Doxorubicin Hydrochloride,Doxorubicin NC,Doxorubicina Ferrer Farm,Doxorubicina Funk,Doxorubicina Tedec,Doxorubicine Baxter,Doxotec,Farmiblastina,Myocet,Onkodox,Ribodoxo,Rubex,Urokit Doxo-cell,DOXO cell,Hydrochloride, Doxorubicin,Urokit Doxo cell
D004334 Drug Administration Schedule Time schedule for administration of a drug in order to achieve optimum effectiveness and convenience. Administration Schedule, Drug,Administration Schedules, Drug,Drug Administration Schedules,Schedule, Drug Administration,Schedules, Drug Administration
D005260 Female Females

Related Publications

M Noguchi, and R Murata, and T Sagoh, and M Yamamoto, and H Ueda, and K Kinoshita, and M Ueta, and H Honda, and K Miyazaki, and T Sasaki, and T Tachibana
January 2004, Akusherstvo i ginekologiia,
M Noguchi, and R Murata, and T Sagoh, and M Yamamoto, and H Ueda, and K Kinoshita, and M Ueta, and H Honda, and K Miyazaki, and T Sasaki, and T Tachibana
December 1987, American journal of clinical oncology,
M Noguchi, and R Murata, and T Sagoh, and M Yamamoto, and H Ueda, and K Kinoshita, and M Ueta, and H Honda, and K Miyazaki, and T Sasaki, and T Tachibana
January 2001, The Cochrane database of systematic reviews,
M Noguchi, and R Murata, and T Sagoh, and M Yamamoto, and H Ueda, and K Kinoshita, and M Ueta, and H Honda, and K Miyazaki, and T Sasaki, and T Tachibana
July 2005, The Cochrane database of systematic reviews,
M Noguchi, and R Murata, and T Sagoh, and M Yamamoto, and H Ueda, and K Kinoshita, and M Ueta, and H Honda, and K Miyazaki, and T Sasaki, and T Tachibana
December 1976, Meditsinskaia radiologiia,
M Noguchi, and R Murata, and T Sagoh, and M Yamamoto, and H Ueda, and K Kinoshita, and M Ueta, and H Honda, and K Miyazaki, and T Sasaki, and T Tachibana
February 1964, Postgraduate medicine,
M Noguchi, and R Murata, and T Sagoh, and M Yamamoto, and H Ueda, and K Kinoshita, and M Ueta, and H Honda, and K Miyazaki, and T Sasaki, and T Tachibana
April 1980, Cancer,
M Noguchi, and R Murata, and T Sagoh, and M Yamamoto, and H Ueda, and K Kinoshita, and M Ueta, and H Honda, and K Miyazaki, and T Sasaki, and T Tachibana
January 2001, Cancer journal (Sudbury, Mass.),
M Noguchi, and R Murata, and T Sagoh, and M Yamamoto, and H Ueda, and K Kinoshita, and M Ueta, and H Honda, and K Miyazaki, and T Sasaki, and T Tachibana
June 2008, Journal of gynecologic oncology,
M Noguchi, and R Murata, and T Sagoh, and M Yamamoto, and H Ueda, and K Kinoshita, and M Ueta, and H Honda, and K Miyazaki, and T Sasaki, and T Tachibana
November 1983, Gan no rinsho. Japan journal of cancer clinics,
Copied contents to your clipboard!